BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 19958649)

  • 1. [The clinical characteristics of primary biliary cirrhosis in China: a systematic review].
    Gu EL; Yao GB
    Zhonghua Gan Zang Bing Za Zhi; 2009 Nov; 17(11):861-6. PubMed ID: 19958649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [No complaints, but constantly elevated cholestatic serum liver tests].
    Kherbèche H
    Praxis (Bern 1994); 2011 Jul; 100(14):865-7. PubMed ID: 21732301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of M2 antibodies in asymptomatic Chinese population.
    Jiang XH; Zhong RQ; Fan XY; Hu Y; An F; Sun JW; Kong XT
    World J Gastroenterol; 2003 Sep; 9(9):2128-31. PubMed ID: 12970922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bezafibrate for primary biliary cirrhosis.
    Rudic JS; Poropat G; Krstic MN; Bjelakovic G; Gluud C
    Cochrane Database Syst Rev; 2012 Jan; 1():CD009145. PubMed ID: 22259000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of biliary enzyme levels and itching as a result of long-term administration of ursodeoxycholic acid in primary biliary cirrhosis.
    Matsuzaki Y; Tanaka N; Osuga T; Aikawa T; Shoda J; Doi M; Nakano M
    Am J Gastroenterol; 1990 Jan; 85(1):15-23. PubMed ID: 1967512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation.
    Kim WR; Poterucha JJ; Jorgensen RA; Batts KP; Homburger HA; Dickson ER; Krom RA; Wiesner RH; Lindor KD
    Hepatology; 1997 Jul; 26(1):22-6. PubMed ID: 9214447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics of primary biliary cirrhosis: a report of 45 cases].
    Zhang F; Jia J; Wang B; Qian L; Yin S; Wang Y; Cui Y; You H; Ma H; Wang H; Zhang C
    Zhonghua Nei Ke Za Zhi; 2002 Mar; 41(3):163-7. PubMed ID: 11940315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Baseline analysis of refractory primary biliary cirrhosis].
    Wang L; Kong F; Zhang X; Xu D; Hu ZJ; Li YZ; Zhang FC
    Zhonghua Yi Xue Za Zhi; 2012 Nov; 92(41):2918-20. PubMed ID: 23328240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical analysis of primary biliary cirrhosis: a report of 42 cases].
    Dai Y; Liang YH; Xie PY; Chen BW; Liu XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2005 Aug; 37(4):410-4. PubMed ID: 16086064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical features of patients with primary biliary cirrhosis].
    He L; Lai Y; Lai L; Luo K; Wang W; Tian Y; Gong G; Zhang M
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1333-9. PubMed ID: 26739075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical features of primary biliary cirrhosis and treatment of it by integrated traditional Chinese and western medicine].
    Jiang J; He M
    Zhong Xi Yi Jie He Xue Bao; 2003 Jul; 1(2):99-102. PubMed ID: 15339578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical analysis of 22 patients with primary biliary cirrhosis].
    Yao D; Xie W; Wang L
    Zhonghua Gan Zang Bing Za Zhi; 2002 Oct; 10(5):344-5. PubMed ID: 12392612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological features of early- and late-stage primary biliary cirrhosis: a comparative study].
    Zhao SX; Zhang YG; Zhou GD; Wang RQ; Zhang QS; Li WC; Ren WG; Nan YM; Zhao JM
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jun; 24(6):412-6. PubMed ID: 27465943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical and pathological analysis of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome].
    Wu CH; Xu XY; Lu HY; Yu YY; Wang GQ
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 36(6):609-11. PubMed ID: 15605092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric-onset primary biliary cirrhosis.
    Dahlan Y; Smith L; Simmonds D; Jewell LD; Wanless I; Heathcote EJ; Bain VG
    Gastroenterology; 2003 Nov; 125(5):1476-9. PubMed ID: 14598264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary biliary cirrhosis.
    Hohenester S; Oude-Elferink RP; Beuers U
    Semin Immunopathol; 2009 Sep; 31(3):283-307. PubMed ID: 19603170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological characteristics of primary biliary cirrhosis patients].
    Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis and treatment of primary biliary cirrhosis.
    Nishio A; Keeffe EB; Ishibashi H; Gershwin EM
    Med Sci Monit; 2000; 6(1):181-93. PubMed ID: 11208308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
    Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
    Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlap of primary biliary cirrhosis and autoimmune hepatitis: Characteristics, therapy, and long term outcomes.
    Yokokawa J; Saito H; Kanno Y; Honma F; Monoe K; Sakamoto N; Abe K; Takahashi A; Yokokawa H; Ohira H
    J Gastroenterol Hepatol; 2010 Feb; 25(2):376-82. PubMed ID: 19817953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.